May, 2024
May 2024
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
2728293031  
Tracey O’Brien: Cancer Conversations – the rapidly evolving landscape of vaping in Australia
May 8, 2024, 17:50

Tracey O’Brien: Cancer Conversations – the rapidly evolving landscape of vaping in Australia

Tracey O’Brien shared on LinkedIn:

“We are thrilled to have more than 600 people registered to join us tonight from 7pm for Cancer Conversations – featuring an expert panel tackling the rapidly evolving landscape of vaping in Australia.

Hear from Kerry Chant, Professor Matthew Peters, Dr. Bronwyn Milne and Kate Reakes in the latest edition of our must-see online series.

It’s not too late to register – sign up here.”

Source: Tracey O’Brien/LinkedIn

Dr. Tracey O’Brien is the NSW Chief Cancer Officer and CEO of the Cancer Institute NSW, Australia. Before her current role, Tracey was Director of the Kids Cancer Centre, Sydney Children’s Hospital, and Director of the Transplant & Cellular Therapy Program. Tracey has held numerous high-profile national and international leadership positions, including Advisory Chair, Cancer Australia; V/Chair (Africa, Asia and Australasia) International Centre for Bone Marrow Transplant Research and V/President of the Australian and New Zealand Children’s Oncology Group. In recognition of her exceptional contributions, Tracey was profiled in 2023 as one of the world’s foremost women in paediatric cancer by the International Society of Paediatric Oncology. In 2019 Tracey was named in the Australian Financial Review’s prestigious Top 10 Women of Influence, winning the Innovation category. In addition to her medical expertise, Tracey has a Master of Law (Health) and executive MBA and serves as a conjoint Professor in Clinical Medicine (UNSW) and Honorary Professor in Science and Engineering (Macquarie University). Dr. O’Brien remains committed to mentoring the next generation of clinician leaders and maintains an active clinical practice in cancer survivorship at Sydney Children’s Hospital.